How To Use CPT Code 0007M

CPT 0007M describes the real-time PCR expression analysis of 51 genes in patients with gastrointestinal neuroendocrine tumors. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, and examples.

1. What is CPT Code 0007M?

CPT 0007M can be used to analyze the expression of 51 genes in patients with gastrointestinal neuroendocrine tumors. This code is used when a lab analyst performs a real-time PCR test on a blood specimen to measure the activity of these genes. The test results are then analyzed using an algorithm to generate a nomogram that represents the nature and progression of the tumor.

2. Official Description

The official description of CPT code 0007M is: ‘Oncology (gastrointestinal neuroendocrine tumors), real-time PCR expression analysis of 51 genes, utilizing whole peripheral blood, algorithm reported as a nomogram of tumor disease index.’

3. Procedure

1. The lab analyst collects a blood specimen from the patient.
2. The lab analyst performs a real-time PCR test on the blood specimen to measure the activity of 51 genes.
3. The test results, along with patient information, are inputted into a computer program.
4. An algorithm is applied to the data to analyze the gene expression and generate a nomogram.
5. The nomogram represents the tumor disease index, providing information about the nature and progression of the tumor.

4. Qualifying circumstances

CPT 0007M is used for patients with gastrointestinal neuroendocrine tumors. This test provides additional information about disease progression and treatment response, and may be ordered in addition to imaging studies. The test requires the use of a blood specimen and the analysis of 51 specific genes using real-time PCR.

5. When to use CPT code 0007M

CPT code 0007M should be used when analyzing the expression of 51 genes in patients with gastrointestinal neuroendocrine tumors. It is important to note that this code includes all the necessary lab tests and algorithmic analysis, so there is no need to separately report the technical lab tests.

6. Documentation requirements

To support a claim for CPT code 0007M, the following documentation is required:

• Patient information, including a diagnosis of gastrointestinal neuroendocrine tumors
• Details of the real-time PCR test performed on the blood specimen
• Results of the gene expression analysis and the generated nomogram

7. Billing guidelines

When billing for CPT code 0007M, ensure that the test is performed on patients with gastrointestinal neuroendocrine tumors. It is important to note that this code includes all the necessary lab tests and algorithmic analysis, so there is no need to separately report the technical lab tests. Additionally, some payers may provide separate reimbursement for the collection of the blood specimen using a different code.

8. Historical information

CPT code 0007M was added to the Current Procedural Terminology system on January 1, 2015. There have been no updates to the code since its addition.

9. Examples

1. A lab analyst performs a real-time PCR analysis of 51 genes in a patient with gastrointestinal neuroendocrine tumors, generating a nomogram to assess the tumor’s nature and progression.
2. Using a blood specimen, the lab analyst analyzes the expression of 51 genes in a patient with gastrointestinal neuroendocrine tumors, providing additional information about disease progression and treatment response.
3. In addition to imaging studies, a physician orders a real-time PCR analysis of 51 genes in a patient with gastrointestinal neuroendocrine tumors to gain insights into the tumor’s nature and progression.
4. A lab analyst performs a real-time PCR test on a blood specimen, quantitatively measuring the activity of 51 genes in a patient with gastrointestinal neuroendocrine tumors, and generates a nomogram to assess the tumor’s nature and progression.
5. Using a blood specimen, the lab analyst analyzes the expression of 51 genes in a patient with gastrointestinal neuroendocrine tumors, providing valuable information about the tumor’s nature and progression.
6. A physician orders a real-time PCR analysis of 51 genes in a patient with gastrointestinal neuroendocrine tumors to complement imaging studies and gain a comprehensive understanding of the tumor’s nature and progression.
7. A lab analyst performs a real-time PCR test on a blood specimen, measuring the activity of 51 genes in a patient with gastrointestinal neuroendocrine tumors, and generates a nomogram to assess the tumor’s disease index.
8. Using a blood specimen, the lab analyst analyzes the expression of 51 genes in a patient with gastrointestinal neuroendocrine tumors, providing crucial information about the tumor’s disease index and progression.
9. A physician orders a real-time PCR analysis of 51 genes in a patient with gastrointestinal neuroendocrine tumors to obtain a comprehensive assessment of the tumor’s disease index and guide treatment decisions.
10. A lab analyst performs a real-time PCR test on a blood specimen, quantitatively measuring the activity of 51 genes in a patient with gastrointestinal neuroendocrine tumors, and generates a nomogram to evaluate the tumor’s disease index.